Correction: Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers: the "all-around warrior" in immunotherapy.

Mol Cancer

Second Ward of Bone and Soft Tissue Tumor Surgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, 110042, Liaoning, China.

Published: September 2024

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11401262	PMC
http://dx.doi.org/10.1186/s12943-024-02121-9	DOI Listing

Publication Analysis

Top Keywords

correction programmed

programmed death

death receptor

receptor pd-1/pd-ligand

pd-1/pd-ligand urological

urological cancers

cancers "all-around

"all-around warrior"

warrior" immunotherapy

correction

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!